OCTAVE SPECIALTY GROUP INC
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
OSG$5.27+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Consolidated Balance Sheets (Unaudited)
Consolidated Balance Sheets
| September 30, | December 31, | |
|---|---|---|
| (Dollars in thousands, except share data) (September 30, 2026 (Unaudited)) | 2026 | 2025 |
| Assets: | ||
| Investments: | ||
| Fixed maturity securities - available-for-sale, at fair value (amortized cost of $139,182 and $123,414) | $132,134 | $122,295 |
| Short-term investments, at fair value (amortized cost of $93,408 and $146,434) | 93,408 | 146,442 |
| Other investments (includes $7,913 and $7,454 at fair value) | 24,531 | 24,971 |
| Total investments (net of allowance for credit losses of $0 and $0) | 250,073 | 293,708 |
| Cash and cash equivalents (including $47,344 and $40,754 of restricted cash) | 79,148 | 68,440 |
| Premium receivables (net of allowance for credit losses of $500 and $500) | 92,036 | 75,085 |
| Commission and fees receivable | 94,613 | 86,549 |
| Reinsurance recoverable on paid and unpaid losses (net of allowance for credit losses of $100 and $100) | 533,679 | 436,092 |
| Deferred ceded premium | 154,911 | 146,365 |
| Policy acquisition costs | 13,578 | 9,732 |
| Intangible assets, less accumulated amortization | 435,835 | 474,998 |
| Goodwill | 534,165 | 540,345 |
| Other assets (net of allowance for credit losses of $350 and $350) | 113,467 | 92,003 |
| Total assets | $2,301,505 | $2,223,317 |
| Liabilities and Stockholders’ Equity: | ||
| Liabilities: | ||
| Unearned premiums | $209,382 | $187,178 |
| Loss and loss adjustment expense reserves | 523,587 | 459,990 |
| Ceded premiums payable | 100,177 | 80,561 |
| Deferred program fees and reinsurance commissions | 7,024 | 6,978 |
| Commissions payable | 127,052 | 115,555 |
| Deferred taxes | 56,097 | 65,217 |
| Long-term debt | 154,767 | 117,558 |
| Accrued interest payable | 30 | 1,343 |
| Other liabilities | 124,564 | 102,771 |
| Total liabilities | 1,302,680 | 1,137,151 |
| Commitments and contingencies (See Note 14) | ||
| Redeemable noncontrolling interest | 194,516 | 252,981 |
| Stockholders’ equity: | ||
| Preferred stock, par value $0.01 per share; 20,000,000 shares authorized; issued and outstanding shares—none | — | — |
| Common stock, par value $0.01 per share; 130,000,000 shares authorized; issued shares: 48,876,882 and 48,876,882 | 489 | 489 |
| Additional paid-in capital | 383,894 | 369,860 |
| Accumulated other comprehensive income (loss) | (1,140) | 8,483 |
| Retained earnings | 333,785 | 370,431 |
| Treasury stock, shares at cost: 3,822,208 and 3,871,598 | (32,638) | (33,473) |
| Total Octave Specialty Group, Inc. stockholders’ equity | 684,390 | 715,790 |
| Nonredeemable noncontrolling interest | 119,919 | 117,395 |
| Total stockholders’ equity | 804,309 | 833,185 |
| Total liabilities, redeemable noncontrolling interest and stockholders’ equity | $2,301,505 | $2,223,317 |
| Octave Specialty Group, Inc. | 2 | Third Quarter 2026 Form 10-Q |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.